Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Aileron Therapeutics reports on new therapeutic drug program

Sep. 10, 2012

Novel DGAT1 inhibitors synthesized by Merck & Co.

Sep. 10, 2012

FDA extends PDUFA date for Ravicti NDA

Sep. 6, 2012

NPS Pharmaceuticals updates plans for Natpara BLA

Sep. 6, 2012

Light study of Contrave experiences accelerated enrollment

Sep. 6, 2012

Novel monoclonal antibodies patented by IRM and Novartis

Sep. 6, 2012

BioSante Pharmaceuticals reports phase III safety data for LibiGel

Sep. 5, 2012

Stem cell gene therapy improves erectile dysfunction in rats

Sep. 5, 2012

New series of GPR119 agonists optimized by Bristol-Myers Squibb

Sep. 4, 2012

Silodosin evaluated for premature ejaculation

Sep. 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...